Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F X Vollenweider

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2001
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserinM E Liechti, M A Geyer, D Hell, et al.
Depression and Anxiety|March 14, 2002
Prepulse inhibition deficits in patients with panic disorderS Ludewig, K Ludewig, M A Geyer, et al.
Journal of Psychiatric Research|March 4, 2000
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humansF X Vollenweider, P Vontobel, I Oye, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 29, 2018
Psilocybin modulates functional connectivity of the amygdala during emotional face discriminationO Grimm, R Kraehenmann, K H Preller, et al.
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Psychiatry Research|December 16, 1998
Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)F X Vollenweider, R P Maguire, K L Leenders, et al.
Molecular Psychiatry|December 18, 2024
Psilocybin increases emotional empathy in patients with major depressionJ Jungwirth, R von Rotz, I Dziobek, et al.
Archives of General Psychiatry|December 15, 2000
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2001
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserinM E Liechti, M A Geyer, D Hell, et al.
Depression and Anxiety|March 14, 2002
Prepulse inhibition deficits in patients with panic disorderS Ludewig, K Ludewig, M A Geyer, et al.
Journal of Psychiatric Research|March 4, 2000
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humansF X Vollenweider, P Vontobel, I Oye, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 29, 2018
Psilocybin modulates functional connectivity of the amygdala during emotional face discriminationO Grimm, R Kraehenmann, K H Preller, et al.
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Psychiatry Research|December 16, 1998
Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)F X Vollenweider, R P Maguire, K L Leenders, et al.
Molecular Psychiatry|December 18, 2024
Psilocybin increases emotional empathy in patients with major depressionJ Jungwirth, R von Rotz, I Dziobek, et al.
Archives of General Psychiatry|December 15, 2000
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.
Pageof 4